Cargando…

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

ABSTRACT: CONCEPT OF DIABETES MELLITUS: Diabetes mellitus is a group of diseases associated with various metabolic disorders, the main feature of which is chronic hyperglycemia due to insufficient insulin action. Its pathogenesis involves both genetic and environmental factors. The long‐term persist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seino, Yutaka, Nanjo, Kishio, Tajima, Naoko, Kadowaki, Takashi, Kashiwagi, Atsunori, Araki, Eiichi, Ito, Chikako, Inagaki, Nobuya, Iwamoto, Yasuhiko, Kasuga, Masato, Hanafusa, Toshiaki, Haneda, Masakazu, Ueki, Kohjiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020724/ https://www.ncbi.nlm.nih.gov/pubmed/24843435 http://dx.doi.org/10.1111/j.2040-1124.2010.00074.x

Ejemplares similares

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus
por: Nakamura, Jiro, et al.
Publicado: (2017)

New glycemic targets for patients with diabetes from the Japan Diabetes Society
por: Araki, Eiichi, et al.
Publicado: (2016)

Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report
por: Goto, Atsushi, et al.
Publicado: (2016)

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
por: Kashiwagi, Atsunori, et al.
Publicado: (2012)

Long‐term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2011)

Protocol for a large-scale prospective observational study with alogliptin in patients with type 2 diabetes: J-BRAND Registry
por: Inagaki, Nobuya, et al.
Publicado: (2014)

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
por: Seino, Yutaka, et al.
Publicado: (2015)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014
por: Kume, Shinji, et al.
Publicado: (2019)

Preparation and culture of bone marrow-derived macrophages from mice for functional analysis
por: Toda, Gotaro, et al.
Publicado: (2020)

Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)
por: Ueki, Kohjiro, et al.
Publicado: (2021)

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
por: Kashiwagi, Atsunori, et al.
Publicado: (2011)

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
por: Kume, Shinji, et al.
Publicado: (2012)

Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
por: Araki, Shin-ichi, et al.
Publicado: (2010)

Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus
por: Takagi, Tomoyuki, et al.
Publicado: (2013)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

An Exploration of Barriers to Insulin Initiation for Physicians in Japan: Findings from the Diabetes Attitudes, Wishes and Needs (DAWN) JAPAN Study
por: Ishii, Hitoshi, et al.
Publicado: (2012)

Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
por: Okada-Iwabu, Miki, et al.
Publicado: (2015)

Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients
por: Araki, Shin-ichi, et al.
Publicado: (2009)

Insulin gene mutations and diabetes
por: Nishi, Masahiro, et al.
Publicado: (2011)

Sodium–glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients
por: Kashiwagi, Atsunori, et al.
Publicado: (2020)

Predictive Properties of Plasma Amino Acid Profile for Cardiovascular Disease in Patients with Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2014)

Therapeutic management of diabetic kidney disease
por: Koya, Daisuke, et al.
Publicado: (2011)

Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial
por: Kaku, Kohei, et al.
Publicado: (2019)

Acute Inhibition of PI3K-PDK1-Akt Pathway Potentiates Insulin Secretion through Upregulation of Newcomer Granule Fusions in Pancreatic β-Cells
por: Aoyagi, Kyota, et al.
Publicado: (2012)

Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2020)

Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan
por: Yasuda, Hitoshi, et al.
Publicado: (2011)

Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study
por: Sasako, Takayoshi, et al.
Publicado: (2021)

Sarcopenia: Loss of mighty armor against frailty and aging
por: Sasako, Takayoshi, et al.
Publicado: (2023)

Randomized controlled trial of single‐agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study
por: Shihara, Nobuyuki, et al.
Publicado: (2011)

Japanese Clinical Practice Guideline for Diabetes 2016
por: Haneda, Masakazu, et al.
Publicado: (2018)

Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2019)

GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
por: Yang, Xu, et al.
Publicado: (2011)

Lung abscess without sepsis in a patient with diabetes with refractory episodes of spontaneous hypoglycemia: a case report and review of the literature
por: Toda, Gotaro, et al.
Publicado: (2014)

Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes
por: Maeda, Shiro, et al.
Publicado: (2011)

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2016)

Solid‐phase extraction treatment is required for measurement of active glucagon‐like peptide‐1 by enzyme‐linked immunosorbent assay kit affected by heterophilic antibodies
por: Hasegawa, Tomonori, et al.
Publicado: (2018)

Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus
por: Sasako, Takayoshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jbv4cb5clbsh0it11ka7flvu7u